
GLRE Valuation
Greenlight Capital Re Ltd
- Overview
- Forecast
- Valuation
- Earnings
GLRE Relative Valuation
GLRE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GLRE is overvalued; if below, it's undervalued.
Historical Valuation
Greenlight Capital Re Ltd (GLRE) is now in the Fair zone, suggesting that its current forward PE ratio of 5.42 is considered Fairly compared with the five-year average of 4.07. The fair price of Greenlight Capital Re Ltd (GLRE) is between 10.19 to 14.22 according to relative valuation methord.
Relative Value
Fair Zone
10.19-14.22
Current Price:13.27
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.69
P/B
Median3y
0.69
Median5y
0.65
22.75
FCF Yield
Median3y
1.81
Median5y
-7.89
Competitors Valuation Multiple
The average P/S ratio for GLRE's competitors is 0.96, providing a benchmark for relative valuation. Greenlight Capital Re Ltd Corp (GLRE) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 8.28%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap

GLRE.O
Greenlight Capital Re Ltd
Loss
Average P/S: 0.96
8.28%
458.55M

GBLI.N
Global Indemnity Group LLC
0.91
-3.24%
429.67M

ACIC.O
American Coastal Insurance Corp
1.52
8.41%
514.00M

AII.N
American Integrity Insurance Group Inc
1.26
62.24%
339.18M

HIPO.N
Hippo Holdings Inc
1.38
29.85%
675.21M

HRTG.N
Heritage Insurance Holdings Inc
0.71
10.57%
637.84M
People Also Watch

RDVT
Red Violet Inc
44.460
USD
-1.27%

ALT
Altimmune Inc
4.080
USD
-0.73%

GHM
Graham Corp
54.920
USD
+1.53%

MGTX
MeiraGTx Holdings PLC
8.370
USD
+0.72%

PROK
ProKidney Corp
3.290
USD
+0.92%

LAAC
Lithium Americas (Argentina) Corp
2.740
USD
0.00%

GAIN
Gladstone Investment Corp
14.020
USD
-0.28%

AGS
PlayAGS Inc
0
USD
+0.08%

BCAL
California Bancorp
16.040
USD
-0.74%

RNAC
Cartesian Therapeutics Inc
13.330
USD
-0.97%
FAQ

Is Greenlight Capital Re Ltd (GLRE) currently overvalued or undervalued?
Greenlight Capital Re Ltd (GLRE) is now in the Fair zone, suggesting that its current forward PE ratio of 5.42 is considered Fairly compared with the five-year average of 4.07. The fair price of Greenlight Capital Re Ltd (GLRE) is between 10.19 to 14.22 according to relative valuation methord.

What is Greenlight Capital Re Ltd (GLRE) fair value?

How does GLRE's valuation metrics compare to the industry average?

What is the current P/B ratio for Greenlight Capital Re Ltd (GLRE) as of Jul 26 2025?

What is the current FCF Yield for Greenlight Capital Re Ltd (GLRE) as of Jul 26 2025?

What is the current Forward P/E ratio for Greenlight Capital Re Ltd (GLRE) as of Jul 26 2025?
